Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Ellen Leich, Itziar Salaverria, Silvia Bea, PhD, Andreas Zettl, MD, Randy D. Gascoyne, MD, Wing-Chung Chan, MD, Rita M. Braziel, MD, Lisa M. Rimsza, MD, Dennis D. Weisenburger, MD, Jan Delabie, MD, Elaine S. Jaffe, MD, Thomas A. Lister, Andrew J. Norton, MD, Louis M. Staudt, MD, PhD, Elena M. Hartmann, MD, Hans-Konrad Mueller-Hermelink, MD, Elias Campo, MD, PhD, German Ott, MD, Andreas Rosenwald, MD

Blood (2007) 110 (11): 360.

https://doi.org/10.1182/blood.V110.11.360.360

Published: 2007

Journal Articles

Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.

Andrew J. Clear, BSc (Hons), Abigail M. Lee, MBBS, Kelly J. Morris, BSc(Hons), Maria Calaminici, MD, PhD, Finlay Macdougall, BA, Rodrigo Proto-Siqueira, PhD, Lindsey K. Goff, PhD, Thomas A. Lister, MD, John G. Gribben, MD DSc

Blood (2007) 110 (11): 2609.

https://doi.org/10.1182/blood.V110.11.2609.2609

Published: 2007

Journal Articles

Phase I Trial of the 131 I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma.

Gairin Dancey, MB, BS, John Violet, PhD, Shokri Othman, BSc, Sweta Parker, MSc, Alan Green, PhD, Surinder Sharma, PhD, Ros Francis, PhD, Natalie Griffin, BSc, Pei-San Chan, BSc, MRPharmS, Peter Amlot, MD, Anmol Malhotra, FRCR, Nicholas Woodward, FRCR, Peter Isaacson, FRCP, Thomas A. Lister, PhD, John Buscombe, MD, Richard Begent, MD, Christopher McNamara, MB, BS

Blood (2007) 110 (11): 648.

https://doi.org/10.1182/blood.V110.11.648.648

Published: 2007

Journal Articles

Enteropathy-Type T-Cell Lymphoma: Clinical Features of a Series of 62 Cases. Jan Delabie, Harald Holte, Andrew Lister and Julie Vose for the International T-Cell Lymphoma Project.

Jan Delabie, MD, Harald Holte, MD, Thomas A. Lister, MD, Julie M. Vose, MD

Blood (2006) 108 (11): 2459.

https://doi.org/10.1182/blood.V108.11.2459.2459

Published: 2006

Journal Articles

The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells.

Simon P. Joel, PhD, Adedayo Oke, PhD, Nichola Foot, BSc, Nick Keen, PhD, Dominique Bonnet, PhD, Thomas A. Lister, MD, Jude Fitzgibbon, PhD

Blood (2005) 106 (11): 3374.

https://doi.org/10.1182/blood.V106.11.3374.3374

Published: 2005

Journal Articles

Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN).

Lindsey K. Goff, PhD, Abigail M. Lee, MBBS, Andrew Clear, BSc, Maria Calaminici, MD, PhD, Andrew J. Davies, MBBS, Suzanne Jordan, BSc, Finlay Macdougall, BA, Janet Matthews, BSc, Andrew J. Norton, MBBS, John G. Gribben, MD DSc, Thomas A. Lister, MD

Blood (2005) 106 (11): 603.

https://doi.org/10.1182/blood.V106.11.603.603

Published: 2005

Journal Articles

The Follicular Lymphoma International Prognostic Index (FLIPI) Can Be a Useful Prognostic Indicator for Patients with Follicular Lymphoma Treated with Combination of Rituximab and Epratuzumab.

Sandra J. Strauss, MD, Franck Morschhauser, MD, Martin Gramatzki, MD, Philippe Solal-Celigny, MD, PhD, Pier L. Zinzani, MD, Andreas Engert, MD, Bertrand Coiffier, MD, Dieter Hoelzer, MD, PhD, Nick Teoh, PhD, William A. Wegener, MD, PhD, David M. Goldenberg, ScD, MD, Ivan D. Horak, MD, Thomas A. Lister, MD

Blood (2005) 106 (11): 4796.

https://doi.org/10.1182/blood.V106.11.4796.4796

Published: 2005

Journal Articles

Mantle Cell and Follicular Lymphoma Samples Demonstrate Differing Sensitivity to Bortezomib in a Primary Culture System.

Lenushka Maharaj, MSc, Sandra J. Strauss, MD, Jim Stec, Thomas A. Lister, Simon P. Joel, PhD

Blood (2004) 104 (11): 3294.

https://doi.org/10.1182/blood.V104.11.3294.3294

Published: 2004

NARROW

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.

Phase I Trial of the 131 I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma.

Enteropathy-Type T-Cell Lymphoma: Clinical Features of a Series of 62 Cases. Jan Delabie, Harald Holte, Andrew Lister and Julie Vose for the International T-Cell Lymphoma Project.

The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells.

Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN).

The Follicular Lymphoma International Prognostic Index (FLIPI) Can Be a Useful Prognostic Indicator for Patients with Follicular Lymphoma Treated with Combination of Rituximab and Epratuzumab.

Mantle Cell and Follicular Lymphoma Samples Demonstrate Differing Sensitivity to Bortezomib in a Primary Culture System.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only